hsp110-gp100 chaperone complex vaccine (Roswell Park Cancer Institute)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namehsp110-gp100 chaperone complex vaccine (Roswell Park Cancer Institute)
Drug Alias Namehsp110-gp100 chaperone complex vaccine (Roswell Park Comprehensive Cancer Center)heat shock protein 110 vaccine (Roswell Park)HSP vaccine (Roswell Park Cancer Institute)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionHeat shock protein HSP105 stimulantsMelanocyte protein PMEL stimulants
TargetsHeat shock protein HSP105Melanocyte protein PMEL
Therapy Area/IndicationsNeoplasmsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRoswell Park Comprehensive Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesRoswell Park Comprehensive Cancer CenterJaeb Center For Health Research Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A